Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

NCT02481830 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

569

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Nivolumab
DRUG: Topotecan
DRUG: Amrubicin

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]